Trial Profile
A Phase III trial of bumetanide with an oral liquid form designed for children (third of 3 studies)
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 23 Mar 2017
Price :
$35
*
At a glance
- Drugs Bumetanide (Primary)
- Indications Autistic disorder; Pervasive child development disorders
- Focus Therapeutic Use
- 23 Mar 2017 New trial record